Cargando…

Vismodegib: A smoothened inhibitor for the treatment of advanced basal cell carcinoma

Incidence of basal cell carcinoma (BCC), the most common skin cancer in humans, is rising. Surgery is the mainstay of treatment but there is no standard of care for locally advanced or metastatic disease. Hedgehog signaling proteins are critical for cell growth and differentiation during embryogenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Aditya, Suruchi, Rattan, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853913/
https://www.ncbi.nlm.nih.gov/pubmed/24350028
http://dx.doi.org/10.4103/2229-5178.120685